367 related articles for article (PubMed ID: 6995485)
1. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.
Hunninghake GW; Gadek JE; Fales HM; Crystal RG
J Clin Invest; 1980 Sep; 66(3):473-83. PubMed ID: 6995485
[TBL] [Abstract][Full Text] [Related]
2. Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages.
Goodman RB; Forstrom JW; Osborn SG; Chi EY; Martin TR
J Biol Chem; 1991 May; 266(13):8455-63. PubMed ID: 1850745
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
Hunninghake GW; Gadek JE; Lawley TJ; Crystal RG
J Clin Invest; 1981 Jul; 68(1):259-69. PubMed ID: 7251862
[TBL] [Abstract][Full Text] [Related]
4. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.
Hunninghake GW; Gallin JI; Fauci AS
Am Rev Respir Dis; 1978 Jan; 117(1):15-23. PubMed ID: 619716
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
7. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
9. The release of elastase, myeloperoxidase, and lysozyme from human alveolar macrophages.
Cohen AB; Chenoweth DE; Hugli TE
Am Rev Respir Dis; 1982 Aug; 126(2):241-7. PubMed ID: 6285785
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of porcine alveolar macrophage-derived neutrophil chemotactic factors I and II; identification of porcine IL-8 and another intercrine-alpha protein.
Goodman RB; Foster DC; Mathewes SL; Osborn SG; Kuijper JL; Forstrom JW; Martin TR
Biochemistry; 1992 Nov; 31(43):10483-90. PubMed ID: 1420165
[TBL] [Abstract][Full Text] [Related]
11. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
12. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor.
Pennington JE; Rossing TH; Boerth LW; Lee TH
J Clin Invest; 1985 Apr; 75(4):1230-7. PubMed ID: 2985653
[TBL] [Abstract][Full Text] [Related]
13. Activation of neutrophils by factors released from alveolar macrophages stimulated with collagen-like polypeptides.
Laskin DL; Soltys RA; Berg RA; Riley DJ
Am J Respir Cell Mol Biol; 1990 May; 2(5):463-70. PubMed ID: 2160256
[TBL] [Abstract][Full Text] [Related]
14. Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.
Rola-Pleszczynski M; Gouin S; Bégin R
Inflammation; 1984 Mar; 8(1):53-62. PubMed ID: 6715031
[TBL] [Abstract][Full Text] [Related]
15. Acute experimental silicosis. Lung morphology, histology, and macrophage chemotaxin secretion.
Lugano EM; Dauber JH; Daniele RP
Am J Pathol; 1982 Oct; 109(1):27-36. PubMed ID: 7124906
[TBL] [Abstract][Full Text] [Related]
16. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients.
Gosset P; Tonnel AB; Joseph M; Prin L; Mallart A; Charon J; Capron A
J Allergy Clin Immunol; 1984 Dec; 74(6):827-34. PubMed ID: 6334110
[TBL] [Abstract][Full Text] [Related]
17. Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.
Schoenberger CI; Hunninghake GW; Kawanami O; Ferrans VJ; Crystal RG
Thorax; 1982 Nov; 37(11):803-9. PubMed ID: 7163997
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil chemotactic activity generation by alveolar macrophages after bleomycin injury.
Wesselius LJ; Catanzaro A; Wasserman SI
Am Rev Respir Dis; 1984 Mar; 129(3):485-90. PubMed ID: 6200017
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
20. Chemotactic and mitogenic components of the alveolar macrophage response to particles ad neutrophil chemoattractant.
Adamson IY; Bowden DH
Am J Pathol; 1982 Oct; 109(1):71-7. PubMed ID: 7124909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
